Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How does AI perform compared to human expert panels in medical Delphi studies? A pilot study through the lens of pathology.

Journal of pathology informatics·2026
Same author

Finding Holes: Pathologist-Level Performance Using AI for Cribriform Morphology Detection in Prostate Cancer.

European urology open science·2026
Same author

Redefining the Landscape of Genitourinary Cancer Precursors: The International Society of Urological Pathology Consensus Recommendations.

European urology·2026
Same author

AI-discovered cellular morphometric biomarkers in needle biopsy of prostate cancer predict neoadjuvant androgen deprivation therapy response and enable therapeutic targeting of mTOR in androgen deprivation therapy-resistant tumors.

Cancer letters·2026
Same author

Label-free fluorescence lifetime imaging for rapid discrimination of high-grade prostate cancer in fresh biopsy cores: a feasibility study.

Journal of biomedical optics·2026
Same author

Radio-pathomic maps of histo-morphometric features trained with whole mount prostate histology distinguish prostate cancer on MP-MRI.

medRxiv : the preprint server for health sciences·2026
Same journal

Salvage Androgen Deprivation Therapy Use After Definitive Radiotherapy With vs Without Androgen Deprivation Therapy in Prostate Cancer.

The Prostate·2026
Same journal

A Simple Cell Culture Assay for Human Prostatic Branching Morphogenesis Spotlights Bone Morphogenetic Protein Signaling as a Therapeutic Target in Benign Prostatic Hyperplasia.

The Prostate·2026
Same journal

Temporal Trends of Metastatic Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era in the United States.

The Prostate·2026
Same journal

Holmium Laser Enucleation of the Prostate (HoLEP) With Proactive Preservation of One Lateral Lobe: A Technique for Benign Prostatic Hyperplasia to Preserve Sexual Function.

The Prostate·2026
Same journal

Clinical Variable-Based Machine Learning for Predicting Early mCRPC Using Exclusively Clinical Variables: Development and Multicenter External Validation.

The Prostate·2026
Same journal

Association Between Intraoperative Prostate Bed Blood Flow and Postoperative Lower Urinary Tract Symptoms After Robot-Assisted Radical Prostatectomy.

The Prostate·2026
See all related articles

Related Experiment Video

Updated: Mar 17, 2026

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.3K

Exosomal ZFPL1 Identifies Neuroendocrine and Stem Cell-Like Prostate Cancer Subtypes?

Neshat Masud1, Johnmesha Sanders1, Kenneth A Iczkowski2

  • 1Replace Louisiana for Los Angeles, Pharmacology, University of Louisiana at Monroe, Monroe, Louisiana, USA.

The Prostate
|March 15, 2026
PubMed
Summary
This summary is machine-generated.

Zinc finger protein-like 1 (ZFPL1) is upregulated in prostate cancer (PC) and linked to aggressive disease. Elevated ZFPL1 levels in plasma show promise as a non-invasive biomarker for PC detection and monitoring.

Keywords:
calcitonincancer markerneuroendocrineprostate cancerzinc finger protein like 1

More Related Videos

Isolation of Stem-like Cells from 3-Dimensional Spheroid Cultures
09:06

Isolation of Stem-like Cells from 3-Dimensional Spheroid Cultures

Published on: December 13, 2019

9.6K
Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
07:16

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

Published on: March 14, 2014

14.7K

Related Experiment Videos

Last Updated: Mar 17, 2026

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.3K
Isolation of Stem-like Cells from 3-Dimensional Spheroid Cultures
09:06

Isolation of Stem-like Cells from 3-Dimensional Spheroid Cultures

Published on: December 13, 2019

9.6K
Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
07:16

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples

Published on: March 14, 2014

14.7K

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Calcitonin (CT) and its receptor drive prostate cancer (PC) progression and metastasis.
  • Identifying CT-regulated genes is crucial for discovering novel PC biomarkers.

Purpose of the Study:

  • To identify CT-inducible genes in prostate cancer.
  • To investigate the role of zinc finger protein-like 1 (ZFPL1) as a potential PC biomarker.

Main Methods:

  • Subtraction hybridization to identify CT-inducible genes.
  • Analysis of ZFPL1 expression in prostate tissues and regulation by CT and androgens.
  • Assessment of exosomal ZFPL1 secretion and plasma levels in PC patients.

Main Results:

  • ZFPL1 expression is significantly higher in malignant prostate tissues compared to benign ones.
  • ZFPL1 expression is upregulated by both CT and androgens.
  • ZFPL1 is secreted via exosomes, with significantly elevated plasma levels in PC patients.

Conclusions:

  • ZFPL1 is a CT- and androgen-regulated protein found in malignant prostate cells.
  • ZFPL1's exosomal secretion and elevated plasma levels suggest its potential as a non-invasive biomarker for PC.
  • ZFPL1's association with aggressive disease markers indicates its utility in monitoring PC progression.